PMID- 30398570 OWN - NLM STAT- MEDLINE DCOM- 20190820 LR - 20190820 IS - 1945-1997 (Electronic) IS - 0098-6151 (Linking) VI - 118 IP - 11 DP - 2018 Nov 1 TI - Evidence for the Prevention of Type 2 Diabetes Mellitus. PG - 730-737 LID - 10.7556/jaoa.2018.158 [doi] AB - Type 2 diabetes mellitus (T2DM) is a common chronic metabolic condition. Before receiving this diagnosis, persons typically have a long period of prediabetes. There is good evidence that T2DM can often be prevented or delayed by means of lifestyle interventions (39%-71%), medications (28%-79%), or metabolic surgery (75%). However, despite consistent data demonstrating their efficacy, these tools are underused, and knowledge about them among primary care physicians is limited. In an effort to engage physicians in addressing this public health crisis more effectively, the authors reviewed the evidence that T2DM can be prevented or delayed in persons at risk. FAU - Shubrook, Jay H AU - Shubrook JH FAU - Chen, William AU - Chen W FAU - Lim, Alegria AU - Lim A LA - eng PT - Journal Article PT - Review PL - United States TA - J Am Osteopath Assoc JT - The Journal of the American Osteopathic Association JID - 7503065 RN - 0 (Hypoglycemic Agents) MH - Combined Modality Therapy MH - Diabetes Mellitus, Type 2/*prevention & control/therapy MH - *Diet MH - Evidence-Based Medicine MH - Female MH - Health Promotion/*organization & administration MH - Humans MH - Hypoglycemic Agents/therapeutic use MH - Life Style MH - Male MH - Prediabetic State/*prevention & control/therapy MH - Preventive Medicine/*organization & administration MH - Program Development MH - Program Evaluation MH - Risk Assessment MH - United States EDAT- 2018/11/07 06:00 MHDA- 2019/08/21 06:00 CRDT- 2018/11/07 06:00 PHST- 2018/11/07 06:00 [entrez] PHST- 2018/11/07 06:00 [pubmed] PHST- 2019/08/21 06:00 [medline] AID - 2712300 [pii] AID - 10.7556/jaoa.2018.158 [doi] PST - ppublish SO - J Am Osteopath Assoc. 2018 Nov 1;118(11):730-737. doi: 10.7556/jaoa.2018.158.